PyClone-VI: Scalable inference of clonal population structures using whole genome data
Abstract
We describe PyClone-VI, a computationally efficient Bayesian statistical method for inferring the clonal population structure of cancers. Our proposed method is 10-100x times faster than existing methods, while providing results which are as accurate. We demonstrate the utility of the method by analyzing data from 1717 patients from PCAWG study and 100 patients from the TRACERx study. Software implementing our method is freely available https://github.com/Roth-Lab/pyclone-vi.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 145
- FWCI
- 4.87
- Field percentile
- top 2%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PhyClone: Accurate Bayesian reconstruction of cancer phylogenies from bulk sequencing
Emilia Hurtado, Alexandre Bouchard‐Côté, Andrew J. L. Roth·BioinformaticsPeer-reviewed·Jun 12, 2025
- SiCloneFit: Bayesian inference of population structure, genotype, and phylogeny of tumor clones from single-cell genome sequencing data
Hamim Zafar, Nicholas E. Navin, … Luay K. Nakhleh·Genome ResearchPeer-reviewed·Nov 1, 2019
- SVclone: inferring structural variant cancer cell fraction
M. Cmero, C. S. Ong, … G. Macintyre·Nature CommunicationsPeer-reviewed·Feb 5, 2020
- VICTree - a Variational Inference method for Clonal Tree reconstruction
Harald Melin, Vittorio Zampinetti, … Jens Lagergren·Lecture notes in computer sciencePeer-reviewed·Jan 1, 2024
- Bayesian inference for copy number intra-tumoral heterogeneity from single-cell RNA-sequencing data
PuXue Qiao, Chun Fung Kwok, … Davis James McCarthy·BiometricsPeer-reviewed·Jul 3, 2025
- Reconstructing complex cancer evolutionary histories from multiple bulk DNA samples using Pairtree
Jeff A. Wintersinger, Stephanie M. Dobson, … Quaid Morris·Blood Cancer DiscoveryPeer-reviewed·Mar 4, 2022